About teva pharmaceutical industries ltd. - TEVA
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
TEVA At a Glance
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a Street
Tel Aviv, Tel Aviv 6944020
| Phone | 972-3-914-8213 | Revenue | 15.85B | |
| Industry | Pharmaceuticals: Generic | Net Income | -559,000,000.00 | |
| Sector | Health Technology | 2023 Sales Growth | 6.263% | |
| Fiscal Year-end | 12 / 2024 | Employees | 37,226 | |
| View SEC Filings |
TEVA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.737 |
| Price to Book Ratio | 1.559 |
| Price to Cash Flow Ratio | 4.106 |
| Enterprise Value to EBITDA | 6.742 |
| Enterprise Value to Sales | 1.85 |
| Total Debt to Enterprise Value | 0.691 |
TEVA Efficiency
| Revenue/Employee | 425,723.956 |
| Income Per Employee | -15,016.386 |
| Receivables Turnover | 4.65 |
| Total Asset Turnover | 0.362 |
TEVA Liquidity
| Current Ratio | 1.019 |
| Quick Ratio | 0.691 |
| Cash Ratio | 0.263 |
TEVA Profitability
| Gross Margin | 48.258 |
| Operating Margin | 20.173 |
| Pretax Margin | -3.937 |
| Net Margin | -3.527 |
| Return on Assets | -1.278 |
| Return on Equity | -7.258 |
| Return on Total Capital | -2.014 |
| Return on Invested Capital | -2.096 |
TEVA Capital Structure
| Total Debt to Total Equity | 269.784 |
| Total Debt to Total Capital | 72.957 |
| Total Debt to Total Assets | 46.574 |
| Long-Term Debt to Equity | 246.216 |
| Long-Term Debt to Total Capital | 66.584 |
Teva Pharmaceutical Industries Ltd. in the News
Stock futures trade mixed ahead of Fed decision
U.S. equity futures were pointing lower ahead of Wednesday's opening bell on Wall Street.